Eat.Fit.Well

Could Gut Microbiome Hold the Key to the Onset of Autism?


by Karina Kaplun, Ph.D. - June 17, 2019


Could Gut Microbiome Hold the Key to the Onset of Autism?

Everything is relative in this world. Until recent advances in the field of human microbiome we thought that we are just humans. It appears now that zillions of non-harmful bacteria residing within our bodies are actually very important to our health. These tiny creatures seem to be involved in major processes in our bodies and may help us understand the developments of some puzzling conditions. One of such conditions is autism-spectrum disorder (ASD).

According to American Psychiatric Association ASD is a complex developmental condition that is characterized by “persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors”. Nowadays, it is estimated that 1 in 59 children is being diagnosed with autism and this number is rising. Not to mention the emotional burden the family of a child with this condition has to go through it is also extremely costly to raise a child with a disability such as autism. It is estimated that raising an autistic child in Canada can vary from $26,000 to $130,000 a person. In addition to the cost these children will turn into adults within the next 15 years and will require a lot of support and assistance from the society and new and effective treatments.

Significant discoveries in gut microbiomes related to ASD

In addition to genetic markers gut microbiota differs in typically or “normally” developing children and ASD individuals. Children with ASD often have gastrointestinal issues which are associated with microbial dysbiosis. Even though there is no consensus yet there is some evidence that children with ASD have a more permeable gut – a condition which is also known as “leaky gut”. Bacterial dysbiosis and “leaky gut” may lead to the passage of microbial toxins, LPS and other metabolites secreted by pathogenic microbes. These molecules can activate the immune response and contribute to inflammation. The inflammation in its turn may affect the development of central nervous system (CNS). Previous research in gut microbiota indicated the significance of microbial composition in the development of nervous system. Prenatal and postnatal periods appear to be equally important for brain development. Loss of maternal vaginal Lactobacillus caused by different factors like stress, antibiotic therapy, inadequate nutrition, obesity, diabetes, eczema and viral infections leads to reduced numbers of these beneficial bacteria in babies. Birth mode (vaginal or C-section), nutrition (breastfeeding or formula) and environment play an important role in the formation of infant microbiota.

Behavioral modulation with Lactobacillus reuteri

One of examples how diet-induced maternal obesity changes maternal microbiome and subsequently alters the microbiome of offspring in mice was shown in the recent study by scientists from Baylor College of Medicine. These researchers hypothesized that altered microbiome, specifically the lack of one particular bacterium - Lactobacillus reuteri, was associated with the autism-like behavior in mice. Indeed, mice born to mothers fed by a high fat diet had significantly reduced numbers of Lactobacillus reuteri and had impaired social behavior. The most striking result of this study was that baby mice born to mothers fed by a high fat diet supplemented with Lactobacillus reuteri had completely normal social behavior. This study was one of the first to demonstrate that changes in gut microbiome can lead to modulation of brain development and function.

Vancomycin study

Another study demonstrating the importance of microbiota in the onset of autism was done by combined efforts of researchers from Los Angeles School of Medicine and Rush Children's Hospital in Chicago. They showed that short term treatments with broad spectrum antibiotic vancomycin improved social behavior of children with ASD.

Microbiota Transfer Therapy as an alternative treatment

Researchers from Arizona State University believe that the key to autism lies in gut microbiota. They checked their hypothesis by transferring gut microbiota from healthy individuals to children with severe autism symptoms. Fecal microbiota transplantation (FMT) has been successfully used for treating Clostridium difficile infection for years. Microbiota transfer therapy (MTT) is a prolonged and more intense version of FMT that included the series of microbiota transfers as well as antibiotics vancomycin and Prilosec 20mg treatments. Scientists monitored these children throughout the next couple of years after the treatment was completed. They found that not only their microbiota composition was positively altered but dramatic social and behavioral improvements were also seen. These improvements remained even two years post treatment. The results of this long-term study is very encouraging and MTT seems to be a very robust and effective method that could offer new and additional options for treating ASD patients.

Another significant study lead by the scientific group of Dr. Mazmanian demonstrated that disturbed microbiota alone maybe the cause of autism-like behavior in mice. Specifically, they took microbiota from severely autistic human donors and transferred it to typical developing control mice and revealed that colonization with ASD microbiota is enough to induce autism-like behaviors.

Current treatment and future perspectives

There are several limitations of the previously mentioned studies. One of them is that most of the behavioral studies have been done in mice and rats which is often hard to translate to humans. The studies with MTT done in Arizona State University are very promising however they were open-label trials without a control for placebo effect. Future studies have to really address this limitation above and look into more factors like genetics, diet and environment.

Currently used intervention involve behavioral treatments, medicines or both. Many people with autism have additional medical conditions such as sleep disturbance, seizures, gastrointestinal symptoms, ADHD, anxiety and others.

Current behavioral interventions of ASD include, but not limited to:

• Applied behavior analysis

• Occupational therapy

• Speech therapy

Some medications that could be used to treat ASD accompanied issues include selective serotonin reuptake inhibitors (SSRIs). SSRIs are commonly prescribed antidepressants, that can help you overcome depression, improve mood and help with anxiety. These are some of the prescribed SSRIs that can be found online at Canada Pharmacy Online. Risperidone (Risperdal) and Aripiprazole (Abilify) are the two medications approved for the treatment of autism-related irritability in children and adolescents aged 5-16 years. They belong to a class of drugs known as atypical antipsychotics.

Prozac (Fluoxetine)

Zoloft (Sertraline)

Abilify (Aripiprazole)

Risperdal (Risperidone)

Here are some of the common ADHD medications, that may elevate the symptoms:

Intuniv (Guanfacine Hydrochloride)

Kapvay (CURRENT UNAVAILABLE)

Strattera (Atomoxetine)

Table 1: Autism Meds Available at CanadaPharmacyOnline.com
Table 1: Autism Meds Available at CanadaPharmacyOnline.com

There is no one size fits all approach when it comes to treating autism. Finding the best and knowledgeable specialists in the field is always the key. Combination of different approaches like behavioral therapies, medication use, reevaluating the diet and lifestyle in general may help improving the ASD symptoms before other more effective therapies appear on the market.

###


Leave your comment:

Your email address will not be published. Required fields are marked with *.

Name*:
Email*:
Comment:
Enter Code:
not case-sensitive
Canadian Pharmacy 
IMPORTANT NOTE:

We stand behind our research and writing, but please be advised this article is no substitute for individual medical attention from your physician or veterinarian. Use the information provided to increase your health-related awareness and always bring your questions or concerns to your doctor or vet for a proper diagnosis. The details we provide are not meant to indicate proper treatment in all conditions or deliver a diagnosis for your condition.
Prescriptions Dispensed from Canada are Dispensed by: Candrug Pharmacy, ID#18985 604-543-8711. Pharmacy Manager: Sanaa Abdelati. This pharmacy is duly licensed in the province of British Columbia, Canada by the College of Pharmacists of BC. If you have any questions or concerns you can contact the college at: 200-1765 West 8th Ave Vancouver, BC V6J 5C6 Canada. All prices are in US dollars.
© Copyright 2006 - 2019 Canada Pharmacy Online. All Rights Reserved.